Insurance benefits of Glivec available for all CML patients

Published: 2003-03-03 06:58:00

Updated: 2003-03-03 06:58:00

The Korea Food and Drug Administration (KFDA) said on February 26 that it modified the conventional indications and dosage & administration of Glivec capsule, antileukemia drug, based on that of Novartis in Switzerland and thus Glivec insurance can cover even chronic myelongenous leukemia (CML) patients in the blast crisis.

According to the KFDA, Glive can be indicated for adult and pediatri...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.